688001-00-5 Usage
Uses
Used in Medicinal Chemistry:
2-(chloromethyl)-3-ethyl-3H-imidazo[4,5-c]pyridine is used as a building block in the synthesis of new compounds for various applications in medicinal chemistry. Its unique structure and reactivity make it a valuable component in the development of innovative therapeutic agents.
Used in Pharmaceutical Research:
In pharmaceutical research, 2-(chloromethyl)-3-ethyl-3H-imidazo[4,5-c]pyridine is utilized for its potential biological activities and therapeutic properties. Studies on this compound focus on exploring its reactivity, biological activities, and potential uses in the creation of novel drugs for treating various diseases and conditions.
Used in Drug Development:
2-(chloromethyl)-3-ethyl-3H-imidazo[4,5-c]pyridine is used as a potential alkylating agent in drug development. Its alkylating properties may contribute to the development of new drugs with unique mechanisms of action and therapeutic benefits.
However, due to its alkylating properties, 2-(chloromethyl)-3-ethyl-3H-imidazo[4,5-c]pyridine should be handled and used with caution, following appropriate safety protocols to ensure the safety of researchers and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 688001-00-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,8,0,0 and 1 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 688001-00:
(8*6)+(7*8)+(6*8)+(5*0)+(4*0)+(3*1)+(2*0)+(1*0)=155
155 % 10 = 5
So 688001-00-5 is a valid CAS Registry Number.
688001-00-5Relevant articles and documents
Regioselective synthesis of an imidazo[4,5-c]pyridine through selective acylation of 3,4-diaminopyridine: Synthesis of CP-885,316
Caron, Stephane,Do, Nga M.,McDermott, Ruth E.,Bahmanyar
, p. 257 - 261 (2006)
CP-885,316 (1), an imidazo[4,5-c]pyridine, 4, was prepared from 3,4-diaminopyridine (9). Two routes were demonstrated using the regioselective introduction of either an acetamide at the 3-position or a tert-butylcarbamate at the 4-position.
